Hip Fractures pp 313-322 | Cite as


  • Kenneth J. Koval
  • Joseph D. Zuckerman


Prevention of hip fractures involves any or all of three basic measures: fall prevention, prevention and treatment of bone fragility, and the use of external hip protectors. Although none of these approaches is without controversy, as a whole they have substantial potential to conserve health-care resources and maintain the quality of life for many elderly individuals.


Bone Mineral Density Femoral Neck Postmenopausal Osteoporosis Thiazide Diuretic Fall Prevention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wagner E, LaCroix A, Grothaus L, et al. Preventing disability and falls in older adults: a population based randomized trial. Am J Public Health 1994; 84:1800–1806.PubMedCrossRefGoogle Scholar
  2. 2.
    Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994; 331:821–827.PubMedCrossRefGoogle Scholar
  3. 3.
    Sherrington C, Lord S. Home exercise to improve strength and walking velocity after hip fracture: a randomized controlled trial. Arch Phys Med Rehabil 1997; 78:208–212.PubMedCrossRefGoogle Scholar
  4. 4.
    Rubenstein L, Robbins A, Josephson K. Effects of an exercise intervention on fallprone elderly men. JAm Geriatr Soc 1994; 41:45.Google Scholar
  5. 5.
    Mulrow C, Gerety M, Kanten D. A randomized trial of physical rehabilitation for very frail nursing home residents. JAMA 1994; 271:519–524.PubMedCrossRefGoogle Scholar
  6. 6.
    MacRae P, Feltner M, Reinsch S. A 1-year exercise program for older women: effects on falls, injuries, and physical performance. Journal of Aging and Physical Activity 1994; 2:127–142.Google Scholar
  7. 7.
    Cummings S, Black D, Nevitt M. Bone density at various sites for prediction of hip fracture. Lancet 1993; 341:72–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Lips P. Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis related fractures. Eur J Clin Invest 1996; 26:436–442.PubMedCrossRefGoogle Scholar
  9. 9.
    Henderson B, Ross R, Lobo R, et al. Re-evaluating the role of progesterone therapy after the menopause. Fertil Steril 1988; 49:9S-15S.Google Scholar
  10. 10.
    Weinstein M, Schiff I. Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynecol Surg 1982; 38:445–455.CrossRefGoogle Scholar
  11. 11.
    Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med 1992; 117:1016–1037.PubMedCrossRefGoogle Scholar
  12. 12.
    Matkovic V, Kostiac K, Simonvic I, et al. Bone status and fracture rates in two regions in Yugoslavia. Am J Clin Nutr 1979; 32:540–549.PubMedGoogle Scholar
  13. 13.
    Holbrook T, Barrett-Connor. E, Wingard DL. Dietary calcium and risk of hip fracture: fourteen-year prospective population study. Lancet 1988; 2:1046–1049.PubMedCrossRefGoogle Scholar
  14. 14.
    Wickham C, Walsh K, Cooper C, et al. Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ 1989; 299:889–892.PubMedCrossRefGoogle Scholar
  15. 15.
    Cooper C, Barker D, Wickham C. Physical activity, muscle strength and calcium intake in fractures of the proximal femur in Britain. BMJ 1988; 297:1443–1446.PubMedCrossRefGoogle Scholar
  16. 16.
    Kreiger N, Gross A, Hunter G. Dietary factors and fracture in postmenopausal women: a case-control study. Int J Epidemiol 1992; 21:953–958.PubMedCrossRefGoogle Scholar
  17. 17.
    Cummings R, Klineberg R. Case control study of dairy product consumption and risk of hip fracture. Am J Epidemiol 1994; 139:S2.Google Scholar
  18. 18.
    Feskanich D, Colditz G, Stampfer M, Willett W. Dietary calcium and bone fractures in middle aged women. Am J Epidemiol 1994; 139:S55.Google Scholar
  19. 19.
    Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323:878–883.PubMedCrossRefGoogle Scholar
  20. 20.
    Aloia J, Vaswani A, Yeh J, et al. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 1994; 120:97–103.PubMedCrossRefGoogle Scholar
  21. 21.
    Reid I, Ames R, Evans M, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993; 328:460–464.PubMedCrossRefGoogle Scholar
  22. 22.
    Chapuy M, Arlot M, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fracture in elderly women. N Engl J Med 1992; 327:1637–1642.PubMedCrossRefGoogle Scholar
  23. 23.
    Dawson-Hughes B, Harris S, Krall E. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995; 61:1140–1145.PubMedGoogle Scholar
  24. 24.
    Lips P, Graafmans W, Ooms M, et al. Vitamin D supplementation and fracture incidence in elderly persons. A randomized placebo-controlled clinical trial. Ann Intern Med 1996; 124:400–406.PubMedCrossRefGoogle Scholar
  25. 25.
    Heikinheimo R, Inkovaara J, Harju E. Annual injection of vitamin D and fractures of aged bone. Calcif Tissue Int 1992; 51:105–110.PubMedCrossRefGoogle Scholar
  26. 26.
    Aloia J. Role of calcitriol in the treatment of postmenopausal osteoporosis. Metabolism 1990; 39:35–38.PubMedCrossRefGoogle Scholar
  27. 27.
    Caniggia A, Nuti R, Martini G, et al. Long term treatment with calcitriol in post menopausal osteoporosis. Metabolism 1990; 39:43–49.PubMedCrossRefGoogle Scholar
  28. 28.
    Ott S, Chestnut C. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989; 110:267–274.PubMedCrossRefGoogle Scholar
  29. 29.
    Kallis D, Garant P, Minkin C. Ultrastructural effects of calcitonin on osteoclasts in tissue culture. J Ultrastruct Res 1972; 39:205–216.CrossRefGoogle Scholar
  30. 30.
    Chambers T, Dunn C. Pharmacological control of osteoclast mobility. Calcif Tissue Int 1983; 35:566–579.PubMedCrossRefGoogle Scholar
  31. 31.
    Gruber H, Ivey J, Baylink D, et al. Long term calcitonin therapy in postmenopausal osteoporosis. Metabolism 1984; 33:295–303.PubMedCrossRefGoogle Scholar
  32. 32.
    Mazzuoli G, Passeri M, Gennari C, et al. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 1986; 38:3–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Kollerup G, Herman A, Brixen E, Lindblad B, Mosekilde L, Sorensen O. Effects of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis. Calcif Tissue Int 1994; 54:12–15.PubMedCrossRefGoogle Scholar
  34. 34.
    Kanis J, Johnell O, Gullberg B, et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fractures. BMJ 1992; 305:1124–1128.PubMedCrossRefGoogle Scholar
  35. 35.
    Wasnich RD, Benfante RJ, Yano K, et al. Thiazide effect on the mineral content of bone. NEngl J Med 1983; 304:344–347.CrossRefGoogle Scholar
  36. 36.
    Ray W, Griffin M, Downey W, Melton LD. Long-term use of thiazide diuretics and risk of hip fracture. Lancet 1989; 1:687–690.PubMedCrossRefGoogle Scholar
  37. 37.
    LaCroix A, Wienpahl J, White L, et al. Thiazide diuretic agents and the incidence of hip fractures. N Engl J Med 1990; 322:286–290.PubMedCrossRefGoogle Scholar
  38. 38.
    Lieberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995; 333:1437–1443.CrossRefGoogle Scholar
  39. 39.
    Watts N, Harris H, Genant H, et al. Intermittent cyclical etidronate treatment on postmenopausal osteoporosis. N Engl J Med 1990; 323:73–79.PubMedCrossRefGoogle Scholar
  40. 40.
    Storm T, Thamsborg G, Steiniche T, et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322:1265–1271.PubMedCrossRefGoogle Scholar
  41. 41.
    Black DM, Cummings SR, Karpf DB, et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348:1535–1541.PubMedCrossRefGoogle Scholar
  42. 42.
    McClung M. Current mineral density data on bisphosphonates in postmenopausal osteoporosis. Bone 1996; 19:195S-198S.CrossRefGoogle Scholar
  43. 43.
    Hayes WC, Meyers ER, Morris JN, et al. Impact near the hip dominates fracture risk in elderly nursing home residents who fall. Calcif Tissue Int 1993; 52:192–198.PubMedCrossRefGoogle Scholar
  44. 44.
    Cummings SR, Nevitt MC. A hypothesis: the causes of hip fractures. J Gerontol 1989; 44:107–111.Google Scholar
  45. 45.
    Parkkari J, Kannus P, Heikkila J, et al. Energy shunting external hip protector attenuates the peak femoral impact force below the theoretical fracture threshold: an invitro biomechanical study under falling conditions of the elderly. J Bone Miner Res 1995; 10:1437–1442.PubMedCrossRefGoogle Scholar
  46. 46.
    Robinovitch S, McMahon T, Hayes W. Force attenuation in trochanteric soft tissues during impact from a fall. J Orthop Res 1995; 13:965–962.CrossRefGoogle Scholar
  47. 47.
    Lauritzen JB, Askegaard V. Protection against hip fractures by energy absorption. Dan Med Bull 1992; 39:91–93.PubMedGoogle Scholar
  48. 48.
    Hayes W, Myers E, Maitland L. Relative risk for fall severity, body habitus and bone density in hip fracture among the elderly. Transactions of the Orthopaedic Research Society 1991; 16:139.Google Scholar
  49. 49.
    Lauritzen JB, Peterson MM, Lund B. Effect of external hip protectors on hip fractures. Lancet 1993; 341:11–13.PubMedCrossRefGoogle Scholar
  50. 50.
    Parkkari J, Kannus P, Poutala J, Vuori I. Force attenuation properties of various trochanteric padding materials under typical falling conditions of the elderly. J Bone Miner Res 1994; 9:1391–1396.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Kenneth J. Koval
    • 1
    • 2
  • Joseph D. Zuckerman
    • 1
    • 2
  1. 1.Department of Orthopaedic SurgeryNYU — Hospital for Joint DiseasesUSA
  2. 2.Orthopaedic SurgeryNYU School of MedicineUSA

Personalised recommendations